SUSTAINED EFFICACY OF BIMEKIZUMAB TREATMENT ASSESSED USING COMPOSITE DISEASE ACTIVITY MEASURES IN PATIENTS WITH PSORIATIC ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO TUMOUR NECROSIS FACTOR INHIBITORS: RESULTS FROM THE PHASE 3 BE COMPLETE STUDY AND ITS OPEN LABEL EXTENSION UP TO 1 YEAR
| Autor: | Coates, L., Landewé, R. B. M., Mcinnes, I., Ritchlin, C. T., Gottlieb, A. B., Orbai, A. M., Warren, R. B., Ink, B., Bajracharya, R., Coarse, J., Merola, J. F. |
|---|---|
| Zdroj: | Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p1775-1776, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|